Clinical Review – Atherogenic dyslipidaemia, CV risk and statin therapy

This Review aims to bring you reports of significant developments of - Atherogenic dyslipidaemia, cardiovascular risk and first-line statin therapy.

Independent commentary is provided by Associate Professor David Sullivan, Staff Specialist at the Royal Prince Alfred and Balmain Hospitals, and Clinical Associate Professor at the University of Sydney.

Please login below to download this issue (PDF)

Subscribe